2'-fluorothymidine has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cass, CE; Eriksson, S; Knaus, EE; Kumar, P; Paproski, RJ; Sjuvarsson, EV; Sun, W; Wiebe, LI; Yang, J; Zhou, A | 1 |
1 other study(ies) available for 2'-fluorothymidine and Osteogenic Sarcoma
Article | Year |
---|---|
Biochemistry and biology of 2'-Fluoro-2'-deoxythymidine (FT), a putative highly selective substrate for thymidine kinase type 2 (TK2).
Topics: Animals; Antineoplastic Agents; Autoradiography; Bone Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Osteosarcoma; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Transgenes | 2012 |